Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Taps Berry Genomics to Facilitate Expansion in China

NEW YORK – Personalis said on Wednesday that it is partnering with Berry Genomics to facilitate its expansion into China.

Personalis said that it plans to form a wholly owned subsidiary in Shanghai, including a laboratory for local customers to use its ImmunoID NeXT platform, a commercial team to support local customers, and general and administrative functions.

Under the terms of the agreement, Berry Genomics will provide Personalis with certain services and local support.

"Having achieved a high degree of scale in our Menlo Park, California operation, we are poised to expand globally, and entering into a partnership with a company that has the track record and capabilities of Berry Genomics will help us accelerate the ramp-up of our operation," Personalis CEO John West said in a statement. "Both companies have benefited from experience founded in the origin of next-generation sequencing, and together we will take it even further."

The ImmunoID NeXT platform leverages deep sequencing to enable researchers studying immune- and precision oncology to comprehensively analyze a tumor and its microenvironment from a single sample across the entire approximately 20,000-gene footprint.

Earlier this year Personalis launched a dedicated pharmaceutical services program to expand beyond its translational and clinical cancer research customer base.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.